Neuropharmacology (2006) 51:11220.10.1016/j.neuropharm.2006.03.004 102 Lopez-RealAReyPSoto-OteroRMendez-AlvarezELabandeira-GarciaJL
Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells
Therapeutic agents targeting CD40/CD40L have been extensively evaluated in clinical trials, with the most notable one being the CD40L monoclonal antibody frexalimab, which has demonstrated significant efficacy in treating relapsing MS [158,159,160]
Glutamate and functional connectivity Support for the excitatory-inhibitory imbalance hypothesis in autism spectrum disorders
Disclosures: Islam Mohamed: Nothing to Disclose, Hazem Abosheaishaa: Nothing to Disclose, Sarah George: Nothing to Disclose, Mira Bhatia: Nothing to Disclose, Lauren Baetje: Nothing to Disclose, Suman Manek: Nothing to Disclose, Nina Henry: Nothing to Disclose, Khushi Parekh: Nothing to Disclose, Yazan Abboud: Nothing to Disclose, Ahmed Salem: Nothing to Disclose, Fouad Jaber: Nothing to Disclose, Dushant Dahiya: Nothing to Disclose, Nikki Duong: Nothing to Disclose 2587 UNHEALTHY PLANT-BASED DIETS ARE ASSOCIATED WITH HEPATIC STEATOSIS IN YOUNG ADULTS Yasmina Tashkent 1 Therese OSullivan 2 Dujinthan Jayabalan 3 Sophie Miller 1 Luis Calzadilla Bertot 3 Steven Taylor 4 Brendan Adler 5 Trevor Mori 3 Lawrie Beilin 3 Oyekoya Ayonrinde 3 John Olynyk 6 Richard Woodman 1 Jocelyn Choo 4 Kate Muller 7 Alan Wigg 1 Geraint Rogers 4 Leon Adams 3 , 1 Flinders University, 2 Edith Cowan University, 3 University of Western Australia, 4 SAHMRI, 5 Envision Medical Imaging, 6 Curtin University, 7 Flinders Medical Center Background: Dietary intake is a key driver of metabolic dysfunction-associated steatotic liver disease
Medical detox is often done in hospitals or treatment centres, but some can do it as outpatients
